Hamilton Lane Incorporated - Class A Common Stock (HLNE)
151.41
+4.47 (3.04%)
Hamilton Lane Inc is a leading investment management firm that specializes in private markets
The company offers a range of services, including advisory, investment management, and market research, tailored to meet the needs of institutional investors and clients seeking to access the private equity and alternative investment landscape. Hamilton Lane leverages its extensive expertise and proprietary technology to provide insights and strategies that help clients navigate complex investment opportunities while aiming to optimize returns and manage risks. The firm is dedicated to enhancing transparency and efficiency in private market investing through innovative solutions and strategic guidance.
Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total consideration of approximately USD $430 Million. The Boards of Directors of both companies have approved the transaction and Mayne Pharma’s Board of Directors has unanimously recommended that its shareholders vote in favor of the transaction. The transaction is expected to close in the second quarter of 2025.
U.S. stocks advanced midday Tuesday, demonstrating resilience despite escalating geopolitical tensions and trade uncertainties between the world’s two largest economies.
Northern Trust (Nasdaq: NTRS) announced today that it has entered into a strategic agreement with Hamilton Lane (Nasdaq: HLNE), a leading global private markets investment management firm, to provide its proprietary software Cobalt LP ® and integrated services to Northern Trust Asset Servicing clients.
